Protagonist Therapeutics Inc (PTGX)
41.49
+1.95
(+4.93%)
USD |
NASDAQ |
Dec 20, 16:00
41.51
+0.02
(+0.05%)
After-Hours: 20:00
Protagonist Therapeutics Price to Book Value: 4.649 for Dec. 20, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Assembly Biosciences Inc | 3.698 |
| Precision BioSciences Inc | 0.5665 |
| Entrada Therapeutics Inc | 1.559 |
| NovaBay Pharmaceuticals Inc | 2.429 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 15.60 |
| PS Ratio | 7.916 |
| Price to Free Cash Flow | 11.18 |
| Price | 41.49 |
| Earnings Yield | 6.41% |
| Market Cap | 2.473B |
| Operating PE Ratio | 17.19 |
| Normalized PE Ratio | 15.60 |